Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
CD19 and CD22 targeted prime CAR-T cells
Chongqing Precision Biotech Co., Ltd
B-ALL
1 trial -
CEA CAR-T cells
Chongqing Precision Biotech Co., Ltd
Solid Tumor
1 trial -
CEA-targeted CAR-T cells
Chongqing Precision Biotech Co., Ltd
Gastric Cancer
3 trials -
CERC-501
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
CET/PT
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
CF 102
Can-Fite BioPharma
Chronic Hepatitis C
1 trial -
CF101
Can-Fite BioPharma
Uveitis, Posterior
1 trial -
CF101
Can-Fite BioPharma
Rheumatoid Arthritis
3 trials -
CF101
Can-Fite BioPharma
Osteoarthritis of the Knee
1 trial -
CF101
Can-Fite BioPharma
Ocular Hypertension
1 trial -
CF101 1mg
Can-Fite BioPharma
Plaque Psoriasis
1 trial -
CF102
Can-Fite BioPharma
Hepatocellular Carcinoma
2 trials -
CF102
Can-Fite BioPharma
Non-alcoholic Steatohepatitis (NASH)
1 trial -
CGT4859
Cogent Biosciences
Intrahepatic Cholangiocarcinoma (Icc)
1 trial -
CGT9486
Cogent Biosciences
Gastrointestinal Stromal Tumors
1 trial -
CGT9486, CGT9486
Cogent Biosciences
Advanced Systemic Mastocytosis
1 trial -
CI-581aa
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
CM-24 and Nivolumab - Dose Escalation
PURPLE BIOTECH LTD.
Solid Tumor
1 trial -
COVAXIN(BBV152)
Biotech Pharmaceutical Co.,
Corona Virus Infection
1 trial -
CR-001
CRESCENT BIOPHARMA, INC.
Locally Advanced / Metastatic Solid Tumors
1 trial -
CRAFT-T
BRIGHT MINDS BIOSCIENCES INC.
Heroin Dependence
1 trial -
CUE-101
Cue Biopharma
Oropharyngeal Squamous Cell Carcinoma
1 trial -
CUE-101
Cue Biopharma
Head and Neck Squamous Cell Carcinoma
1 trial -
CYB003
BRIGHT MINDS BIOSCIENCES INC.
Major Depressive Disorder
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources